History of Monkeypox & more recent GoF research on Monkeypox
A report by the House Committee Energy and Commerce about their investigation into GoF Monkeypox research.
Media involvement intensified during election season 2022 following CoV jabs in 2021 — and seems to be spinning a similar narrative in 2024.
Shingles pox has been common following the CoV injections, with people including me getting them in 2022, when coincidentally there was a media driven increase in Monkeypox. That may be the same pattern we are seeing again in 2024. But rumor-mill does have risk of worse GoF -aerosolized risk- Monkeypox floating around, so preventive self-care might be a good idea anyway.
The rumor-mill also suggests that Monkeypox had been a lab creation to begin with, rather than truly being a newly discovered monkey disease. On the continent of Africa, it has been a ‘new’ disease - the largest outbreak dates back to only 2017 and allegedly Nigeria was the source of spread of the new disease to other nations. The very first cases there were allegedly in 1971 and 1978. The US had an outbreak of Monkeypox in 2003. (Figure 3, Mauldin, et al., 2022) This reference also has a thorough record of when Monkeypox started showing up. (Bunge, et al., 2022)
“The name monkeypox originates from the initial discovery of the virus in monkeys in a Danish laboratory in 1958 [4]. The first case in humans was diagnosed in 1970 in a 9-month-old baby boy in Zaire (now the Democratic Republic of the Congo, DRC) [5].” (Bunge, et al., 2022)
The mystery here, is how the discovery of “Monkeypox virus” in a Danish laboratory that was working on smallpox vaccines for an outbreak in a Danish colonies, ended up becoming endemic in Africa. The assumption would be that the monkeys came from Africa - but the monkeys came from Singapore and had been treated experimentally with smallpox vaccine. What do Singapore monkeys have to do with Africa? Or were the Danish colonies in Nigeria?
“Monkeypox virus got its name when it was first isolated in Copenhagen in 1958 from cynomolgus macaques (Macaca fascicularis) imported from Singapore to Denmark and used as laboratory animals for polio vaccine–related vaccine research after an outbreak of smallpox-like vesicular disease occurred in their colonies. [1]” (biopharma.media/monkeypox-2022-full-review-4331/)
Danish colonies in Africa were called the “Gold Coast” and were in Western Africa roughly where Ghana is today. (Wikipedia) Ghana’s first cases of Monkeypox were reported in 2022. (Brave AI summary) That is a real puzzler how a problem discovered in Danish labs in 1958 in monkeys purchased from Singapore, ended up in Nigeria in 1971.
**Addition: Rat, Rat Says, 20 mins ago, Liked by Jennifer Depew, R.D.
I guess «their colonies» is intended to mean «monkey colonies» here, not «Danish colonies».
The last tropical Danish colony ended in 1917 (Danish West Indies sold to the USA). Danish colonies in Africa (modern day Ghana) and India ended in mid-19th century. I believe there are no monkeys in Faroe islands and Greenland (outside of military bases, that is :).
**So, there was a polio like outbreak in monkeys in Singapore and they decided to bring them back to Copenhagen? or the colonies of lab monkeys in Copenhagen developed smallpox-like rashes and the lab decided to research that for polio vaccines? It doesn’t explain how Copenhagen lab monkey disease ended up endemic in Nigeria a couple decades later.
Clues - Monkeypox prevalence seemed initially to be related to the childhood vaccine age group and later with the adults vaccinated against smallpox:
“Our analysis shows that in the early years (1970–1989), monkeypox was primarily a disease of young children, with a median age at presentation of 4 to 5 years old; this increased to 10 years of age in 2000–2009 and 21 years in 2010–2019. Regarding age at death in monkeypox cases, 100% of deaths were in children <10 years of age in the early years, while for the years 2000–2019, age <10 years accounted for only 37.5% of deaths. These data appear to be consistent with the global intensified smallpox eradication program that began in 1967 [86] and the cease of routine smallpox vaccination by the 1980s following its eradication [3]. In the 2000s, only adults older than 20–25 years would have had a history of smallpox vaccination, leaving the age groups below 20 years vulnerable. Interestingly, the median age of monkeypox cases increased from 10 to 21 years in the next decade. Indeed, most cases were either likely too young to have been vaccinated or were born after the cessation of routine smallpox vaccination, as in the more recent outbreaks.” […]
“The highest percentage of vaccinated cases (21%) was found in the US outbreak [40].” (Bunge, et al., 2022)
My take-home point: “Monkeypox” appears to be a vaccine injury side effect or a live vaccine caused case of “We-are-not-calling-it-Smallpox-because-we-eradicated-smallpox-with-vaccines-ISN’T-THAT-WONDERFUL!”. We are also not calling it vaccinia pox - vaccine-induced pox, because the official goal of vaccines is not to cause to disease but to prevent it. We need the optics to look good, even if the skin health is looking quite bad.
“The global smallpox eradication campaign, led by the World Health Organization (WHO), was launched in 1959 and ultimately succeeded in eradicating the disease in 1980.” (Brave AI summary)
And a reveal:
“Newly unsealed documents have revealed an explosive confession from the U.S. Food and Drug Administration (FDA) about the so-called “monkeypox virus.” According to one document published by Massey, the FDA admits that there is “zero scientific evidence” to prove that the “monkeypox virus” even exists. @Slay_News_” - TheTexasOne, @TexasRepublic71, https://x.com/TexasRepublic71/status/1827401128642015287?t=KSr9Zokp0bTgHLGpxo6y8w&s=19
I am not sure if this is the newly unsealed documents but another post had a link to a 73 page House Committee investigation report. The link to download it is within the article: (energycommerce.house.gov) via DivaPatriot, (x.com/TeamAmerica2020) timeline image below is from the article.
‘Interim Staff Report on Investigation into Risky MPXV Experiment at the National Institute of Allergy and Infectious Diseases’, June 11, 2024, Energy & Commerce Chair Rodgers; the 73 page report is also viewable/downloadable in my Sync file as a pdf.
Timeline of the Investigation into GoF work on Monkeypox
The House Committee report:
‘Interim Staff Report on Investigation into Risky MPXV Experiment at the National Institute of Allergy and Infectious Diseases’, June 11, 2024, Energy & Commerce Chair Rodgers; the 73 page report is also viewable/downloadable in my Sync file, and in my Dropbox.
Treatment for smallpox being stockpiled by the US
TPOXX medication, Tecovirimat, can help prevent replication and the government bought 20,000 doses of that but are working on a vaccine for the rest of us according to a Thread by (x.com/CanariesBlue). *TPOXX vaccines are being stockpiled for smallpox readiness according to the CDC website. (cdc.gov/poxvirus/mpox/clinicians/tecovirimat-ea-ind.html)
Monkey virus hunter Nathan Wolfe (Metabiota) has been working on monkeypox since 2005 with Anne Rimoin (UCLA). (thread) Reminder, Hunter Biden’s Rosemont Seneca invested $$$ in Metabiota. - Blue Canaries Click through to read more (if logged in to X): (x.com/CanariesBlue)
Refuse the ‘Mpox’ ACAM2000 vaccine! Do NOT Comply!
It is actually a live oral smallpox vaccine with known adverse risks that would be contraindicated for use by CoV injected or exposed people.
This jab may cause ‘vaccinia pox’. Preventing “Monkeypox” while causing ‘vaccinia pox’ is not a win for the patient and it might shed to other people too.
The Mpox vaccine being promoted is dangerous. It has known adverse risks similar to what has been seen following the CoV injections. If there is a history of those jabs or passive exposure illness, or VAIDS or AIDS/HIV+, or eczema, heart disease, and it is not for use in pregnancy or for infants under 12 months old. Shedding from it is a risk from those injected to people in the household who are in the protected category, as it is a live virus vaccine. See MPox Part 3: (Substack).
“Any specific immunizations cannot prevent monkeypox infections and illnesses. The vaccinations (Vaccinia virus-based vaccines) developed for smallpox is being evaluated for use to prevent MPXV. Until 2019, the United States’ only OPXV vaccine option was ACAM2000. The OPXV family of viruses is the foundation for ACAM2000, which is based on a recombinant strain of the Vaccinia virus that is both alive and homologous. ACAM2000 has been associated with serious side effects (including progressive vaccinia, eczema vaccinatum, and myopericarditis) because of the virus’s ability to replicate. (Sahu, et al., 2023, pdf)
Two vaccines are approved for Monkeypox by the FDA (See excerpt below) but we are only hearing about the smallpox ACAM2000 vaccine and it is a live-virus-based vaccine with passive exposure risks - it can symptoms by shedding live virus to non-injected people. Getting the ACAM2000 may leave you with a side effect of ‘vaccinia’ pox and may cause it in your grandmother or children too. That isn’t really the goal of ‘preventive’ health care, is it?
Mystery solved - the US has (*had in 2022) a stockpile of over a 100 million doses of the smallpox ACAM2000 vaccine.
This link has more information about the JYNNEOS vaccine: (biopharma.media/monkeypox-2022-full-review-4331/)
“Two vaccines are licensed by FDA for the prevention of orthopoxvirus infections. JYNNEOS is a live virus vaccine that uses nonreplicating modified vaccinia Ankara (MVA) which is licensed for prevention of smallpox and monkeypox in adults aged ≥18 years (18). Because JYNNEOS contains replication-deficient MVA, it does not present a risk for disseminated infection, autoinoculation, or transmission to others (15). JYNNEOS vaccine is administered as a series of two doses given 28 days apart (18). ACAM2000 is a replication-competent live vaccinia virus vaccine licensed for prevention of smallpox that is administered as a single dose (19). ACAM2000 was derived from Dryvax, the vaccine used in the eradication of smallpox (19).”
Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection, US, Aug 2022, (CDC.gov)
Having had a history of smallpox vaccine may be protective against Monkeypox, but it would not help an active case and Monkeypox may still occur even if vaccinated against smallpox. “The highest percentage of vaccinated cases (21%) was found in the US outbreak [40].” (Bunge, et al., 2022)
MPox post series:
Previous posts on this topic have other self-care tips including how I used black seed oil for ‘shingles’ in 2022.
I made this series into a document with a clickable Table of Contents. (sync.com pdf)
"Mpox clade" - our new disease X is still Monkeypox, but elevated IgG4 and VAIDS following CoV jabs may be the real cause of a pox 'epidemic'. "Mpox clade" may have PCR testing & Trojan Horse jabs on the way . . . Do not comply. Clearly, preserving human health is not really the goal. Aug. 17, 2024, (Substack)
GoF history on Monkeypox & a better Lysine/arginine ratio reduces risk of shingles or Herpes - and CoV in my own case. Also, food sources of arginine and lysine and spirulina might help herpes too and African geranium. Aug. 19, 2024, (Substack)
Mpox jabs are dangerous and may be deadly for people with VAIDS/AIDS or eczema. Passive exposure from jabbed people to those at risk may also be sharing the adverse reaction risk to the unjabbed person. Heart disease and eye conditions are also contraindicated for the Mpox jabs. Aug. 20, 2024, (Substack)
Mpox part 4 - Geert says no one should be getting the Mpox jabs, roughly. And more natural health aids via Pat on Telegram, thanks!, Aug. 22, 2024, (Substack)
»> Mpox Series in a document with clickable Table of Contents for level one and two headings, sync.com pdf.
Disclaimer: This information is being provided for educational purposes within the guidelines of Fair Use and is not intended to provide individual health care guidance.
Not on the article. Excellent writing.
Why that house committee. They have no energy or commerce??
Many thanks for your research and helpful advice.